GlassScriptPhysician profile
Kerry Giedd
NPI 1831220144
$135,643.43
in general payments reported to CMS, 2019-2025
14 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $24K · 2021: $17K · 2022: $12K · 2023: $21K · 2024: $17K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Travel and Lodging: $7,796 · Food and Beverage: $3,891 · Entertainment: $148 · Education: $9.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,250.00 |
| Travel and Lodging | $7,796.03 |
| Food and Beverage | $3,890.78 |
| Entertainment | $148.38 |
| Education | $9.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $67,836.95 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $59,611.84 | 2022-2025 | Biotrue, Infuse, Miebo |
| Sun Pharmaceutical Industries INC. | $4,621.10 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $1,500.00 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $821.22 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $628.35 | 2019-2025 | Precision 1 |
| Optos, INC. | $148.38 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $141.60 | 2023-2024 | Misight Contact Lens, Myday Contact Lens |
| Abb Con-Cise Optical Group LLC | $133.38 | 2019-2024 | Spectacle Lenses, Contact Lens |
| Optovue, INC. | $108.44 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $69.01 | 2025 | Xdemvy |
| Osmotica Pharmaceutical Corp. | $23.16 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Giedd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.